Garuda Therapeutics

Garuda Therapeutics was a clinical-stage biotechnology company founded in 2021 by Sean Morrison and David Scadden and headquartered in Massachusetts (Cambridge, later Natick), developing off-the-shelf, self-renewing, HLA-compatible, transgene-free hematopoietic (blood) stem cell therapies intended to remove the dependency on a matched donor or on patient cells in the treatment of hematologic malignancies, sickle cell disease, beta-thalassemia and bone marrow failure. It raised roughly $184M across a $72M Series A and a $50M Series A-1 closed in March 2025, backed by OrbiMed Advisors, Northpond Ventures, Cormorant Asset Management and Kyowa Kirin. It is a therapeutics developer, not a software company: it never published an API, SDK, developer portal or machine-readable specification, and its website garudatx.com no longer serves company content and now resolves to a GoDaddy parking lander.

Garuda Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Cell Therapy, and Stem Cells.

1.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-09-08 · rubric v0.20.0
0 APIs
CompanyBiotechnologyTherapeuticsCell TherapyStem CellsLife SciencesHealthcareDefunct

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-08 · rubric v0.20.0
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero: never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and several others — scorable at all.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/garuda-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Resources

Other 1

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: garuda-therapeutics
name: Garuda Therapeutics
description: 'Garuda Therapeutics was a clinical-stage biotechnology company founded in 2021 by Sean Morrison and David Scadden
  and headquartered in Massachusetts (Cambridge, later Natick), developing off-the-shelf, self-renewing, HLA-compatible, transgene-free
  hematopoietic (blood) stem cell therapies intended to remove the dependency on a matched donor or on patient cells in the
  treatment of hematologic malignancies, sickle cell disease, beta-thalassemia and bone marrow failure. It raised roughly
  $184M across a $72M Series A and a $50M Series A-1 closed in March 2025, backed by OrbiMed Advisors, Northpond Ventures,
  Cormorant Asset Management and Kyowa Kirin. It is a therapeutics developer, not a software company: it never published an
  API, SDK, developer portal or machine-readable specification, and its website garudatx.com no longer serves company content
  and now resolves to a GoDaddy parking lander.'
url: https://raw.githubusercontent.com/api-evangelist/garuda-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
specificationVersion: '0.23'
created: '2026-08-16'
modified: '2026-08-16'
tags:
- Company
- Biotechnology
- Therapeutics
- Cell Therapy
- Stem Cells
- Life Sciences
- Healthcare
- Defunct
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: SecondaryMarketListing
  name: Forge Global secondary-market listing
  url: https://forgeglobal.com/garuda-therapeutics_stock/
x-website-status:
  domain: garudatx.com
  serves_company_content: false
  observed: '2026-08-16'
  state: parked
  note: Deliberately NOT wired as a Website pointer. garudatx.com returns a 114-byte HTML stub that redirects to /lander,
    the GoDaddy parking single-page app. The Wayback Machine shows the real company site through 2025-01-22, Australian online-casino
    SEO spam at the 2025-10-09 snapshot, and a ~538-byte holding page from 2026-01-20 onward. garudatherapeutics.com 301s
    to a HugeDomains for-sale listing. The only live URL for this company is a trading-venue listing, which is a venue page
    and not a company web presence (roadmap#56), so it is typed SecondaryMarketListing rather than Website.
x-enrichment:
  date: '2026-08-16'
  status: minimal
  artifacts_added: 1
  pass: local-v1
x-coverage:
  state: none
  reason: defunct
  detail: Garuda Therapeutics is a clinical-stage cell-therapy developer that never had a developer surface, and its domain
    garudatx.com has since left its control — it served Australian online-casino SEO spam in October 2025 and now returns
    a 114-byte stub redirecting to a GoDaddy parking lander, while garudatherapeutics.com 301s to a HugeDomains for-sale page.
  evidence:
  - url: https://garudatx.com/
    status: 200
  - url: https://garudatx.com/lander
    status: 200
  - url: https://garudatx.com/.well-known/agent-card.json
    status: 200
  - url: https://garudatx.com/openapi.json
    status: 200
  - url: https://garudatherapeutics.com/
    status: 200
  checked: '2026-08-16'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/garuda-therapeutics"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/garuda-therapeutics/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/garuda-therapeutics/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no form to fill in. Signing in shares your email address with us — we store it to create your key and to recognise you if you sign in with another provider. See our Privacy Policy and Terms.

A second provider on the same verified email joins the account you already have.